Table 3 Univariate analysis of factors potentially affecting overall survival
From: Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma
n | Median survival (months) | p | |
|---|---|---|---|
Age (years) | |||
≥70 | 14 | 10.0 | 0.034 |
<70 | 14 | 14.0 | - |
Sex | |||
Male | 17 | 12.0 | 0.339 |
Female | 11 | 14.0 | - |
ECOG performance status | |||
1 or 2 | 13 | 5 | 0.000 |
0 | 15 | - | - |
Tumor size (mm) | |||
>50 | 15 | 10.0 | 0.008 |
≤50 | 13 | 18.0 | - |
BED-10 (Gy) | |||
>70 | 22 | 14.0 | 0.243 |
<70 | 6 | 5.0 | - |
CA19-9 | |||
>37 | 15 | 10.0 | 0.312 |
≤37 | 13 | 15.0 | - |
Chemotherapy | |||
Yes | 15 | 18.0 | 0.474 |
No | 13 | 12.0 | - |